The learning curve for laparoscopic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer: Implications for compliance with existing guidelines

BJU International

Volumn 112, Issue 3, 2013, Pages 346-354

  Eden, Christopher G ^a   Zacharakis, Evangelos ^a   Bott, Simon ^b  

^a ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^b FRIMLEY PARK HOSPITAL   (United Kingdom)

Author keywords

laparoscopy; prostate cancer; radical prostatectomy

Indexed keywords

CEPHALOSPORIN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CANCER GRADING; CANCER PATIENT; CANCER STAGING; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; GLEASON SCORE; HEALTH CARE QUALITY; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMEDIATE RISK PATIENT; LAPAROSCOPIC EXTENDED PELVIC LYMPHADENECTOMY; LAPAROSCOPIC RADICAL PROSTATECTOMY; LAPAROSCOPIC SURGERY; LEARNING CURVE; MAJOR CLINICAL STUDY; OPERATION DURATION; OPERATIVE BLOOD LOSS; PELVIS LYMPH NODE; PELVIS LYMPHADENECTOMY; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RISK; SURGEON; SURGICAL APPROACH; TREATMENT FAILURE; VASCULAR ACCESS;

LAPAROSCOPY; PROSTATE CANCER; RADICAL PROSTATECTOMY;

ADULT; AGED; GUIDELINE ADHERENCE; HUMANS; LAPAROSCOPY; LEARNING CURVE; LYMPH NODE EXCISION; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK ASSESSMENT;

EID: 84879882883     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11671.x     Document Type: Article

References (35)

1. Briganti A, Chun FK, Salonia A, et al. Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer. Eur Urol 2006; 50: 1006-1013.
2. Masterson TA, Bianco F Jr, Vickers AJ, et al. The association between total and positive lymph node counts and disease progression in clinically localized prostate cancer. J Urol 2006; 175: 1320-1325.
3. Joslyn SA, Konetybc BR,. Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer. J Urol 2006; 68: 121-125.
4. Messing EM, Manola J, Yao J, et al. Eastern Cooperative Oncology Group study EST 3886. Immediate versus deferred androgen deptivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy. Lancet Oncol 2006; 7: 472-479.
5. Hyndman ME, Mullins JK, Pavlovich CP,. Pelvic node dissection in prostate cancer: extended, limited or not at all? Curr Opin Urol 2010; 20: 211-217.
6. American Urological Association. AUA Guideline for the management of clinically localised prostate cancer. Available at: http://www.auanet.org/ content/clinical-practice-guidelines/clinical-guidelines.cfm?sub=pc. Accessed October 2012
7. European Association of Urology. EAU Guidelines on prostate cancer. Available at: http://www.uroweb.org/gls/pdf/08%20Prostate%20Cancer- LR%20March%2013th%202012.pdf. Accessed October 2012.
8. Briganti A, Larcher A, Abdollah F, et al. Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores. Eur Urol 2012; 61: 480-487.
9. James Buchanan Brady Urological Institute. The Partin Tables. James Buchanan Brady Urological Institute, Johns Hopkins Hospital, Baltimore, MD, USA. Avialable at: http://urology.jhu.edu/prostate/partintables.php. Accessed October 2012
10. Memorial Sloan-Kettering Cancer Centre. Prostate Cancer Nomograms: Pre-Treatment. Memorial Sloan-Kettering Cancer Centre, New York, NY, USA. Available at: http://nomograms.mskcc.org/Prostate/PreTreatment.aspx. Accessed October 2012
11. D'Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 969-974.
12. Briganti A, Chun FK, Salonia A, et al. Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer. BJU Int 2006; 98: 788-793.
13. Heidenreich A, Ohlmann CH, Polyakov S,. Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy. Eur Urol 2007; 52: 29-37.
14. Bader P, Burkhard FC, Markwalder R, Studer UE,. Is a limited lymph node dissection an adequate staging procedure for prostate cancer? J Urol 2002; 168: 514-518.
15. Cheng L, Zincke H, Blute ML, Bergstralh EJ, Scherer B, Bostwick DG,. Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer 2001; 91: 66-73.
16. Bader P, Burkhard FC, Markwalder R, Studer UE,. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? J Urol 2003; 169: 849-854.
17. Daneshmand S, Quek ML, Stein JP, et al. Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. J Urol 2004; 172: 2252-2255.
18. Boorjian SA, Thompson RH, Siddiqui S, et al. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era. J Urol 2007; 178: 864-871.
19. Heidenreich A, Von Knobloch R, Varga Z, et al. Extended pelvic lymphadenectomy in men undergoing radical retropubic prostatectomy (RRP)-an update on >300 cases. J Urol 2004; 171: 312, abstract #1183.
20. Burkhard FC, Schumacher M, Studer UE,. The role of lymphadenectomy in prostate cancer. Nat Clin Pract Urol 2005; 2: 336-342.
21. Mattei A, Fuechsel FG, Bhatta Dhar N, et al. The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study. Eur Urol 2008; 53: 118-125.
22. Eden CG, King D, Kooiman GG, Adams TH, Sullivan ME, Vass JA,. Transperitoneal or extraperitoneal laparoscopic radical prostatectomy: does the approach matter? J Urol 2004; 172: 2218-2223.
23. Young A, Miller JP, Azarow K,. Establishing learning curves for surgical residents using Cumulative Summation (CUSUM) Analysis. Curr Surg 2005; 62: 330-334.
24. Grunkemeier GL, Wu YX, Furnary AP,. Cumulative sum techniques for assessing surgical results. Ann Thorac Surg 2003; 76: 663-667.
25. de Oliveira Filho,. The construction of learning curves for basic skills in anesthetic procedures: an application for the cumulative sum method. Anesth Analg 2002; 95: 411-416.
26. Eden CG, Neill MG, Louie-Johnsun MW., The first 1000 cases of laparoscopic radical prostatectomy in the UK: evidence of multiple learning curves. BJU Int 2009; 103: 1224-1230.
27. Musch M, Klevecka V, Roggenbuck U, Kroepfl D,. Complications of pelvic lymphadenectomy in 1,380 patients undergoing radical retropubic prostatectomy between 1993-2006. J Urol 2008; 179: 923-929.
28. Heidenreich A, Varga Z, Von Knobloch R., Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol 2001; 167: 1681-1687.
29. Clark T, Parekh DJ, Cookson MS, et al. Randomised prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. J Urol 2003; 169: 145-147.
30. Stein JP, Penson DF, Cai J, et al. Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer. J Urol 2007; 177: 876-882.
31. Allaf ME, Palapattu GS, Trock BJ, Carter HB, Walsh PC,. Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J Urol 2004; 172: 1840-1844.
32. Briganti A, Capitano U, Chun FK, et al. Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer. Eur Urol 2008; 54: 794-804.
33. Weingartner K, Ramaswamy A, Bittinger A, Gerharz EW, Voge D, Reidmiller H,. Anatomical basis for pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic. J Urol 1996; 156: 1969-1971.
34. Bolenz C, Gupta A, Hotze T, et al. Cost comparison of robotic, laparoscopic and open radical prostatectomy for prostate cancer. Eur Urol 2010; 57: 453-458.
35. Wagner M, Sokoloff M, Daneshmand S,. The role of pelvic lymphadenectomy for prostate cancer-therapeutic? J Urol 2008; 179: 408-413.